A St. Louis jury has awarded a Virginia woman a record-setting $110.5 million in the latest lawsuit alleging that using Johnson & Johnson’s baby powder caused cancer.

The jury ruling Thursday night for 62-year-old Lois Slemp of Wise, Va., comes after three previous St. Louis juries awarded a total of $197 million to plaintiffs who made similar claims. Those cases, including the previous highest award of $72 million, are all under appeal. About 2,000 state and federal lawsuits are in courts nationwide over concerns about health problems caused by prolonged use of talcum powder.

Slemp, who was diagnosed with ovarian cancer in 2012, blames her illness on her use of the company’s talcum-containing products for more than 40 years. Her cancer has spread to her liver. Although she was too ill to attend the trial, an audiotape of her deposition testimony was played. In it she said, “I trusted Johnson & Johnson. Big mistake.”

Jim Onder, one of her attorneys, said Friday that Slemp was “thrilled” when the verdict was shared with her in a phone call and that she hoped it would “send a message.” He said she is too sick to talk to reporters.


Johnson & Johnson, based in Brunswick, N.J., said in a statement that it would appeal and disputed the scientific evidence behind the plaintiffs’ allegations. The company also noted that a St. Louis jury found in its favor in March and that two cases in New Jersey were thrown out by a judge who said there wasn’t reliable evidence that talc leads to ovarian cancer.

“We are preparing for additional trials this year, and we will continue to defend the safety of Johnson’s Baby Powder,” the statement said.

The suit also named supplier Imerys Talc, which was held liable for $50,000. Imerys, which has been held accountable in only one other talcum case, said in a statement that it is “confident in the consensus of government agencies and professional scientific organizations that have reviewed the safety of talc.”

Talc is a mineral that is mined from deposits around the world, including in the U.S. The softest of minerals, it’s crushed into a white powder. It has been widely used in cosmetics and other personal care products to absorb moisture since at least 1894, when Johnson & Johnson’s baby powder was launched. But it’s mainly used in a variety of other products, including paint and plastics.


Much research has found no link or a weak one between ovarian cancer and using baby powder for feminine hygiene, and most major health groups have declared talc harmless. Still, the International Agency for Research on Cancer classifies genital use of talc as “possibly carcinogenic.”

Attorneys with Onder, Shelton, O’Leary & Peterson, the firm that handled the St. Louis cases, cited other research that began connecting talcum powder to ovarian cancer in the 1970s. They cite case studies showing that women who regularly use talc on their genital area face up to a 40% higher risk of developing ovarian cancer.

Johnson & Johnson shares fell 44 cents on Friday, or 0.4%, to $123.51.

ALSO


2 killed when cargo plane goes off runway in West Virginia

Family of boy killed on Kansas waterslide to receive $20 million

Puerto Rico, $70 billion in debt, seeks bankruptcy protection

UPDATES:


1:35 p.m.: This article was updated with Johnson & Johnson’s stock movement.

Noon: This article was updated with testimony from Lois Slemp, comment from Jim Onder and information about and comment from Imerys Talc.

This article was originally published at 6:55 a.m.